Irving, Texas, US, 13th March 2024 / Sciad Newswire / Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for online purchase in Canada, Europe, South Korea and the U.S..
London, UK, 7th February 2024 / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen's University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kid.
Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions Devens, MA, US / 7th February 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) will attend two ISPE events in Fe.
BugBiome was announced as the winner of the Discovery Spark life science business support programme at the GIANT Health Healthcare Investment Show on 5th December. BugBiome will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment .
Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S. London, UK, 30th October 2023 / Sciad Newswire / Laverock Therapeutics, developer of a unique gene silencing platform for the creation of programmable advanced therapies, is pleased to an.